Proteomics signatures associated with cognitive trajectories: evidence from the English Longitudinal Study of Ageing
Gong, J.; Bloomberg, M.; Scholes, S.; Hao, X.; Salih, D. A.; ZANINOTTO, P.; Steptoe, A.
Show abstract
Alzheimer's disease and related dementias (ADRD) pose a growing global health challenge, with early detection critical to slowing cognitive decline and prevent ADRD. We analyzed high-throughput plasma proteomics in 2,460 cognitively healthy adults from the English Longitudinal Study of Ageing (ELSA) to identify proteins linked to 15-year cognitive trajectories, including verbal fluency, episodic memory, and orientation. Mixed-effect linear models revealed 34 proteins associated with faster orientation decline and 18 with accelerated episodic memory decline. Enrichment analyses implicate extracellular matrix remodeling, immune signaling, apoptosis, and lysosomal-autophagic pathways in cognitive deterioration. Subgroup analyses showed sex-specific effects, highlighting heterogeneity in proteomics signatures in cognitive aging. Notably, ten identified proteins are targets of drugs under clinical investigation, suggesting opportunities for therapeutic repurposing. These findings define a plasma proteomic signature associated with decline in domain-specific cognitive functions, offering promising biomarkers and druggable targets to prevent or slow age-related cognitive decline.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 95%
- Sex differences in the association of mild behavioral impairment with cognitive aging 95%
- Trimethylamine N-oxide reduces neurite density and plaque intensity in a murine model of Alzheimer disease 94%
Similar papers in this journal
- Transcriptional and translational regulation of pathogenesis in Alzheimer's disease model mice 94%
- Investigating the Efficacy of Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects: A Pilot Study 94%
- DNA methylation age acceleration is associated with incident cognitive impairment in the Health and Retirement Study 94%
Similar papers in this journal
- GPR39 Localization in Aging Human Brain and Correlation of Expression and Polymorphism with Vascular Cognitive Impairment 95%
- Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease 93%
- Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies 93%